Parallel Advisors, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Parallel Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 05, 2019	SELL	$5.4 - $15.5 $124 - $356	-23 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$3.6 - $6.22 $82 - $143	23 New	23 $0
Q4 2017 Feb 13, 2018	SELL	$8.69 - $14.59 $1,042 - $1,750	-120 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$5.73 - $9.44 $687 - $1,132	120 New	120 $1,000
Q3 2017 Nov 14, 2017	SELL	$5.73 - $9.44 $687 - $1,132	-120 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	120	120 $2,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.